The NuMatuSeal Story

“I’m Dr. Ismael Matus, an interventional pulmonologist with over 20 years of experience in bronchoscopy and airway management.


Over the course of my career, it became increasingly clear that while bronchoscopy has evolved—especially with advances like robotic platforms and image-guided navigation—the airway devices we rely on have not kept pace. We’re now targeting subcentimeter pulmonary lesions with remarkable precision, yet we’re still using endotracheal tubes and supraglottic airways that were never designed to accommodate bronchoscopy, let alone enhance it.


I recognized a critical need for an airway device that could serve both anesthesia and bronchoscopy needs—without compromise. Existing devices fall short in supporting the shared airway: they can hinder efficient ventilation and oxygenation for anesthesiologists, and can challenge access and maneuverability for pulmonologists. This gap becomes even more pronounced with rigid bronchoscopy, where no dedicated, comprehensive airway solution has ever existed—until now.


That’s why I created the NuMatuSeal—the first airway device specifically engineered to support all types of bronchoscopy, while also serving as an ideal alternative for general anesthesia cases traditionally managed with supraglottic airways.


NuMatuSeal is designed to bridge the interface between anesthesia and bronchoscopy. Its versatility allows for safe and efficient airway management across a range of procedural needs—from flexible to rigid bronchoscopy—setting a new standard for collaboration and care in the shared airway.”

Meet the Team

Dr. Ismael Matus, Founder and Chief Medical Officer

Ismael Matus, M.D., FCCP,  DAABIP is the
Director of Interventional Pulmonology at the Helen F. Graham Cancer Center and Research Institute at Christiana Care in Newark, Delaware.

He joined Christiana Care from Georgetown University Hospital in Washington, D.C., where he served as assistant professor of interventional pulmonology with the Division of Pulmonary, Critical Care and Sleep Medicine.

He is board-certified in Interventional pulmonology by the American Association for Bronchology and Interventional Pulmonology and in Pulmonary Medicine by the American Board of Internal Medicine.

He earned his medical degree from Universidad Autónoma de Centro America, Costa Rica. He completed his internal medicine residency at the State University of New York (SUNY) Upstate Medical University in Syracuse, NY, a recipient of the Arnold P. Gold Foundation Humanism and Excellence in Teaching Award. He completed his Pulmonary and Critical Care fellowship at the Georgetown University Medical Center; thereafter he received additional training in Interventional Pulmonology at the Thoraxklinik, University of Heidelberg, Germany.

Dr. Matus has special interests and expertise in advanced diagnostic and therapeutic rigid bronchoscopy, complex airway disease, medical thoracoscopy, transbronchial lung cryobiopsy, pleural diseases and lung cancer. He has presented his research internationally and has published the findings of his clinical research in peer-reviewed journals.

His clinical research interests have focus on both management and development of clinical pathways for malignant pleural effusions, promoting individualized ambulatory care of iatrogenic pneumothorax, leveraging thoracic ultrasonography as an alternative for chest Xray imaging after transbronchial lung cryobiopsies for interstitial lung diseases and examining older technologies for new applications such as utilizing cryobiopsies for evaluating
peripheral lung lesions.

Most of these efforts share a consistent theme: rethinking standardized care in favor of more personalized, streamlined approaches that improve quality of life and reduce unnecessary hospitalizations and healthcare costs.

Dr. Matus’s investigative philosophy is rooted in continuous improvement and a willingness to challenge routine clinical practices. This perspective led him to conduct an international survey examining current practices in rigid bronchoscopy and their supportive anesthesia approaches, identifying both significant variations and areas of consensus. Insights from this work directly influenced the design of the NuMatuSeal device, reflecting a careful alignment between innovation and real-world procedural challenges and clinical need.

Contact Dr. Matus

Adam Hamby, CEO

Adam Hamby is a lifelong entrepreneur with a background in Real Estate as well as Mergers & Acquisitions. Adam earned a Bachelor of Science degree in Business Administration with a concentration in Finance from the University of Delaware.

Adam is a 2016 fellow of Leadership Delaware (LDI) which is a nonprofit focused on furthering the development of young leaders, resulting in a positive impact on the Delaware community and beyond.

Adam has served on the Board of Directors at Community Powered Federal Credit Union since 2012 and currently serves as Treasurer. He also serves on the Board of Directors of the Delaware Safety Council, a nonprofit, 501© (3) dedicated to promoting the protection of life and health at home, at work, on the highway and in the community.

Contact Adam